Find participating medical centers and current study status in each of them

    Find participating medical centers

    A clinical trial to look at how safe RO6874281 is in combination with another drug called pembrolizumab, and to look at how well the combination works to treat melanoma.

    A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma

    • Cancer
    • Melanoma
    • Metastatic Melanoma
    • Skin Cancer
    • Malignant Melanoma

    For the latest version of this information please go to www.forpatients.roche.com